http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105327390-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
filingDate 2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105327390-B
titleOfInvention A kind of controllable object phase strontium-doped calcium phosphate powder and preparation method
abstract The invention belongs to biomedical material technologies, disclose a kind of controllable object phase strontium-doped calcium phosphate powder and preparation method.The preparation method is:According to the molar ratio of (Ca+Sr)/P=1.67, by (NH 4 ) 3 PO 4 ·3H 2 O solution is added drop-wise to Ca (NO 3 ) 2 ·4H 2 O and (NH 4 ) 3 PO 4 ·3H 2 It is reacted in the mixed solution of O, product obtains strontium-doped calcium phosphate presoma powder through centrifuge washing, drying after grinding;Then by strontium-doped calcium phosphate presoma powder at a temperature of 900~1200 DEG C heat preservation sintering, controllable object phase strontium-doped calcium phosphate powder is obtained after cooling.The present invention is capable of the strontium-doped calcium phosphate two-phase powder of controllable preparation difference HA and β TCP ratios by adjusting strontium doping amount, has better bioactivity and application prospect compared with traditional calcium phosphate powder.
priorityDate 2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19437590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454637486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453448475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451041010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355457
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448932107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10207414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158169199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829

Total number of triples: 35.